인쇄하기
취소

CJ and Pfizer Korea jointly to promote Campto.

Published: 2005-06-07 06:56:00
Updated: 2005-06-07 06:56:00
CJ pharmaceutical division and Pfizer Korea have made a joint marketing promotion agreement for Campto (Irinotecan Hcl), a anti-cancer drug for the metastasis colon cancer starting from June 1, which may provide a chance for the both parties to create a synergic effects in the marketing and selling of Campto.

The two parties have adopted a model called "Double Hitting" of allocating their s...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.